284
Participants
Start Date
June 1, 2021
Primary Completion Date
December 31, 2022
Study Completion Date
December 31, 2022
Penicillin Major Determinant (PrePen) Skin Testing
Skin testing followed by oral challenge with amoxicillin 250 mg single dose
Direct Oral challenge
Direct oral challenge with test dose of amoxicillin 25mg followed by amoxicillin 250mg single dose
Louisiana State University, New Orleans
University of Washington-Harborview Medical Center, Seattle
Indiana University School of Medicine
OTHER
Wake Forest University Health Sciences
OTHER
Louisiana State University Health Sciences Center in New Orleans
OTHER
University of Washington
OTHER
Johns Hopkins University
OTHER